Therapies - 18 News by MDC

Tip: You can further refine your news selection by departments, countries and industries.

Therapies - 18 News by MDC

Tip: You can further refine your news selection by departments, countries and industries.

image description

Sharpening the gene scissors together

Max Delbrück Centre and biotech start-up AlgenScribe cooperate

29-Jul-2024 - The Max Delbrück Center, Berlin, and the biotech company AlgenScribe from Nice have agreed to cooperate to further develop their gene-editing tools. The aim is to utilize synergies, accelerate research, and ultimately develop cell therapies for genetically determined diseases. A special kind of ...

therapies cell therapies CRISPR
image description

Captain T Cell secures seed financing round

Start-up develops first-in-class efficacy-enhanced TCR-T cells for solid tumors that are not addressed by existing therapies

28-May-2024 - Captain T Cell, a spin-off from the Max Delbrück Center, raised €8.5 million in startup funding. The startup focuses on developing T cells to target solid tumors. The funds are intended to move a new generation of T cell therapies towards the clinic. Captain T Cell GmbH announced the successful ...

therapies cell therapies T-cell therapies
image description

Computer-engineered DNA to study cell identities

“We can follow with our eyes the color in a petri dish when we give a treatment”

12-Feb-2024 - A new computer program allows scientists to design synthetic DNA segments that indicate, in real time, the state of cells. Reported by the Gargiulo lab in “Nature Communications”, it will be used to screen for anti-cancer or viral infections drugs, or to improve gene and cell-based ...

therapies immunotherapies artificial DNA
image description

Starting up with highly promising immunotherapies

Fighting cancer with specially equipped T cells

04-Oct-2023 - After spending many years researching together, a group of scientists has founded CARTemis Therapeutics, a spin-off from the Max Delbrück Center. Uta Höpken, Armin Rehm, Anthea Wirges, and Mario Bunse want to use novel CAR T-cell therapies to help patients with cancers that are currently ...

therapies CAR-T cell therapies cell therapies
image description

New muscle therapy gets fast-track boost

Berlin start-up could soon be helping children with previously incurable muscle diseases thanks to an accelerated approval process

01-Aug-2023 - To help bring therapies for rare muscle diseases in children to market sooner, the Berlin-based start-up MyoPax, a spin-off from the Max Delbrück Center and Charité – Universitätsmedizin Berlin, has now received a boost from the U.S. Food and Drug Administration (FDA). The company has been ...

therapies stem cell therapie clinical trials
image description

Regenerative therapies for previously incurable muscle diseases

Million euro support for MyoPax

22-Sep-2022 - MyoPax, a new spin-off of the Max Delbrück Center and Charité, receives a 1.3 million euros loan to jump-start its entrepreneurial activities. The start-up develops regenerative therapies for previously incurable muscle diseases using its innovative muscle stem cell technology. The BioInnovation ...

therapies cell therapies gene therapy
image description

Unstoppable against blood cancer

What was previously only possible in the mouse model, the researchers now show in human cells

26-Jul-2022 - For people with certain forms of leukemia, lymphoma or multiple myeloma, they are sometimes the last chance to beat the cancer: Treatments with chimeric antigen receptor T cells, or CAR T cells for short. For this purpose, T cells are taken from the patient's blood to equip them with artificially ...

therapies cell therapies immunotherapies
image description

The tricks of lymphomas

Cancer cells create protective niches for themselves

05-Nov-2021 - Cellular immunotherapies have so far not been very effective against non-Hodgkin’s lymphoma. A team led by Armin Rehm of the MDC has discovered a possible reason. As they describe in “Cell Reports”, this cancer induces changes in the large blood vessels through which immune cells normally migrate ...

therapies immunotherapies cancer
image description

How cells move and don’t get stuck

New insight for developmental biology and potential cancer treatment

22-Jan-2021 - Theoretical physicists from Berlin teamed up with experimental physicists from Munich to determine the precise mechanics involved in cell motility. Cell velocity, or how fast a cell moves, is known to depend on how sticky the surface is beneath it, but the precise mechanisms of this relationship ...

therapies cancer therapy cell migration
image description

A potent weapon against lymphomas

Mice with leukemia were cured

19-Jan-2021 - MDC researchers have developed a new approach to CAR T-cell therapy. The team has shown in Nature Communications that the procedure is very effective, especially when it comes to fighting follicular lymphomas and chronic lymphocytic leukemia, the most common type of blood cancer in adults. The ...

therapies CAR-T cell therapies immunotherapies
Search all

These products might interest you

Thermo Scientific TSX Universal Series Ultra-low Temperature Freezer New

Thermo Scientific TSX Universal Series Ultra-low Temperature Freezer by Thermo Fisher Scientific

Over 80 years of innovation packed into the next-generation ultra-low temperature freezer

The pinnacle of reliability, sustainability, and innovation

ultra deep freezers
View product
ZE5 Cell Analyzer

ZE5 Cell Analyzer by Bio-Rad Laboratories

Fast and precise flow cytometry for high-throughput analyses

Reduce labour and increase productivity in drug discovery

flow cytometers
View product
Linkit® AX

Linkit® AX by Sartorius

Precise aliquoting solutions for cell and gene therapy

Uniform liquid distribution and full traceability

filling stations
View product
CellGenix® Growth Factors and Cytokines

CellGenix® Growth Factors and Cytokines by Sartorius

Recombinant growth factors without animal products

Optimised cell culture for T cells and MSCs in gene therapy

reagents
View product
Recombumin® Elite

Recombumin® Elite by Sartorius

ICHQ7 cGMP-compliant albumin for biotechnological applications

Increase consistency and safety for gene therapies and vaccines

reagents
View product
HEK Media

HEK Media by Sartorius

Serum-free cell culture media for HEK cells

Optimised for HEK293 cells and viral vector production, ISO 9001 certified

cell culture media
View product
Ksep® Consumable Kits

Ksep® Consumable Kits by Sartorius

Ksep® Kits: Cell clarification and harvesting made easy

Automated solutions for higher yield and quality in bioprocessing

consumables
View product
Biopreservation Solutions

Biopreservation Solutions by Sartorius

Cryopreservation without animal components: For maximum cell recovery

cGMP production and over 300 references - perfect for cell banks and therapies

cell culture reagents
View product
Ampha X30

Ampha X30 by Amphasys

Ampha X30 Single-Cell Analyzer: for the fast and accurate cell analysis

Efficient cell analysis of viability, count and cell status – without dyes, markers, and incubation

cell analyzers
View product
LPD_GPS_ Centrifugation Project

LPD_GPS_ Centrifugation Project by Thermo Fisher Scientific

Powerful at Every Turn – Meet the NEW General Purpose Centrifuge Family

The most versatile centrifuges designed to fit your application needs

centrifuges
View product
Show all therapies
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 27,239 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now